Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_Sales_Revenues_January_2024_espi.pdfNotification for Sales revenues for January 2024

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 8 / 2024
Date of issue: 2024-02-19
Short name of the issuer
SOPHARMA AD
Subject
Notification for Sales revenues for January 2024
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) notifies that for January 2024 the Company recorded an increase in sales of 32% compared to the same month of the previous year, incl. 16% increase in domestic sales and 44% increase in export sales.
Annexes
File Description
SFA_Sales_Revenues_January_2024_espi.pdf
SFA_Sales_Revenues_January_2024_espi.pdf		 Notification for Sales revenues for January 2024

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-02-19 Ognian Donev Executive director
20240219_130502_1823367697_SFA_Sales_Revenues_January_2024_espi.pdf

Pobierz